Editorial: Fetal antigens and tumour cells

August 1974
British Medical Journal;8/3/1974, Vol. 3 Issue 5926, p299
Academic Journal
No abstract available.


Related Articles

  • "Humors from tumors": carcinoembryonic antigen, alpha-fetoprotein, and digestive system cancer. Kraft, Summer C.; Kraft, S C // Annals of Internal Medicine;Mar72, Vol. 76 Issue 3, p502 

    Editorial. Comments on tumor-associated fetal substances. Presence of carcinoembryonic antigen in fetal digestive system; Detection of circulating levels of antigen through radioimmunoassay; Availability of methods to judge responses to X-ray treatment.

  • Regulatory T cells, tumour immunity and immunotherapy. Weiping Zou // Nature Reviews Immunology;Apr2006, Vol. 6 Issue 4, p295 

    Tumours express a range of antigens, including self-antigens. Regulatory T cells are crucial for maintaining T-cell tolerance to self-antigens. Regulatory T cells are thought to dampen T-cell immunity to tumour-associated antigens and to be the main obstacle tempering successful immunotherapy...

  • Trial and error.  // New Scientist;03/24/2001, Vol. 169 Issue 2283, p3 

    Editorial. Discusses the outlook for fetal cell research. Trial in the United States in which patients who received fetal cell transplants experienced side effects; Public opinion of the research; Outlook for stem cell research.

  • Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Marks, A; Sutherland, D R; Bailey, D; Iglesias, J; Law, J; Lei, M; Yeger, H; Banerjee, D; Baumal, R // British Journal of Cancer;5/1/99, Vol. 80 Issue 3/4, p569 

    M2A antigen is an oncofetal antigen associated with germ cell neoplasia, present in testis on fetal gonocytes and re-expressed on carcinoma in situ (CIS) and germ cell tumours. We developed a panel of monoclonal antibodies (mAb), M2A (IgG2a), D1-26 (IgG2b) and D2-40 (IgG1), to this antigen in...

  • Editorial. Fetal cells in maternal blood: current and future perspectives. Hahn, S; Sant, R; Holzgreve, W // MHR: Basic Science of Reproductive Medicine;Jun98, Vol. 4 Issue 6 

    Editorial. Presents developments in non-invasive alternative for prenatal diagnosis methods which could influence prospect research. Enrichment for fetal cells in the blood of pregnant women; Research work on trophoblasts, fetal leukocytes and fetal erythrocytes; Question of fetal cell...

  • Immune interactions between mother and fetus.  // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Aug2004, Vol. 9 Issue 2, p209 

    Focuses on the immunology aspects in maternal-fetal exchange. Physiological role of fetal trophoblast; Link between T cell expressing CD antigens and immune response activation; Association between pregnancy and immunological tolerance.

  • Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Coulie, Pierre G.; Van den Eynde, BenoĆ®t J.; van der Bruggen, Pierre; Boon, Thierry // Nature Reviews Cancer;Feb2014, Vol. 14 Issue 2, p135 

    In this Timeline, we describe the characteristics of tumour antigens that are recognized by spontaneous T cell responses in cancer patients and the paths that led to their identification. We explain on what genetic basis most, but not all, of these antigens are tumour specific: that is, present...

  • Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. Sideras, K; Bots, S J; Biermann, K; Sprengers, D; Polak, W G; IJzermans, J N M; de Man, R A; Pan, Q; Sleijfer, S; Bruno, M J; Kwekkeboom, J // British Journal of Cancer;6/9/2015, Vol. 112 Issue 12, p1911 

    Background:Identification of tumour antigens is crucial for the development of vaccination strategies against hepatocellular carcinoma (HCC). Most studies come from eastern-Asia, where hepatitis-B is the main cause of HCC. However, tumour antigen expression is poorly studied in low-endemic,...

  • Tumour immunogenicity: Editorial selection demystified. Burgess, Darren J. // Nature Reviews Cancer;Apr2012, Vol. 12 Issue 4, p227 

    The article discusses research being done on tumour immunogenicity. It references the studies "Expression of tumour-specific antigens underlies cancer immunoediting," by M. DuPage and colleagues and "Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting," by H....

  • Opinion: Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nicchitta, Christopher V. // Nature Reviews Immunology;May2003, Vol. 3 Issue 5, p427 

    Early investigations into the immune surveillance of chemically-induced sarcomas led to two important concepts in tumour immunobiology: one, tumour rejection can be elicited by immune recognition of tumour antigens; and two, tumours express unique sets of antigens, which are known as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics